Independent information. England-wide.Public data. Clear sources.

NCT06091254 · OLYMPIA-1

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Registered research study with 5 identifiable England locations. See source dates, location-specific recruitment and the original study record.

Study facts

Conditions recorded
Follicular Lymphoma (FL)
Lead sponsor
Regeneron Pharmaceuticals
Study type
Interventional
Overall status
Recruiting · this can differ by location
Age range in the record
18 Years to Not specified
Sex eligibility field
All
Healthy volunteers accepted
No, according to the record
Phase
Phase3
Study record last updated
10 August 2026
Study team last verified status
2026-08

These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.

England study locations

A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.

Location in the sourceLocal recruitment statusGeographic connection
Royal Cornwall Hospitals NHS Trust, Royal Cornwall Hospital

Truro · TR1 3LJ

RecruitingCare in Cornwall

England postcode

Derriford Hospital and the Royal Eye Infirmary

Plymouth · PL6 8DH

WithdrawnCare in Plymouth

England postcode

University Hospitals Dorset

Bournemouth · BH77DW

RecruitingCare in Bournemouth, Christchurch and Poole

England postcode

Norfolk and Norwich University Hospital

Norwich · NR4 7UY

RecruitingCare in South Norfolk

England postcode

Barking, Havering and Redbridge University Hospitals NHS Trust

Romford · RM7 0AG

RecruitingCare in Havering

England postcode

Questions for the research team

  • Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
  • What visits, tests, possible risks and follow-up would participation involve?
  • Are travel costs or accessibility arrangements available?
  • How would participation affect my usual care, and what happens if I withdraw?

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.